Jaguar Health Inc (JAGX)
4.22
-0.07
(-1.63%)
USD |
NASDAQ |
May 31, 16:00
4.30
+0.08
(+1.90%)
After-Hours: 20:00
Jaguar Health Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2022 | -1.675M |
September 30, 2022 | 9.164M |
June 30, 2022 | -1.258M |
March 31, 2022 | -0.006M |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | -0.007M |
September 30, 2020 | -0.007M |
June 30, 2020 | 0.00 |
March 31, 2020 | -0.007M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | -0.007M |
March 31, 2019 | 0.00 |
Date | Value |
---|---|
December 31, 2018 | -0.0065M |
September 30, 2018 | -0.0178M |
June 30, 2018 | -1.564M |
March 31, 2018 | -1.564M |
December 31, 2017 | -1.557M |
September 30, 2017 | -1.069M |
June 30, 2017 | 0.6271M |
March 31, 2017 | 2.292M |
December 31, 2016 | 2.384M |
September 30, 2016 | 3.407M |
June 30, 2016 | -1.245M |
March 31, 2016 | -2.910M |
December 31, 2015 | -3.003M |
September 30, 2015 | -4.503M |
June 30, 2015 | 0.00 |
March 31, 2015 | -0.0551M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.675M
Minimum
Dec 2022
9.164M
Maximum
Sep 2022
0.5634M
Average
-0.007M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
BioSig Technologies Inc | -0.141M |
BioVie Inc | 12.73M |
Entero Therapeutics Inc | -- |
Genprex Inc | -0.0674M |
Adial Pharmaceuticals Inc | -- |